Literature DB >> 31730938

Rat multicellular 3D liver microtissues to explore TGF-β1 induced effects.

Vincenzo Prestigiacomo1, Anna Weston2, Laura Suter-Dick3.   

Abstract

Chronic liver damage can lead to fibrosis, encompassing hepatocellular injury, activation of Kupffer cells (KC), and activation of hepatic stellate cells (HSC). Inflammation and TGF-β1 are known mediators in the liver fibrosis adverse outcome pathway (AOP). The aim of this project was to develop a suitable rodent cell culture model for the investigation of key events involved in the development of liver fibrosis, specifically the responses to pathophysiological stimuli such as TGF-β1 and LPS-triggered inflammation. We optimized a single step protocol to purify rat primary hepatocytes (Hep), HSC and KC cells to generate 3D co-cultures based on the hanging drop method. This primary multicellular model responded to the profibrotic cytokine TGF-β1 (1 ng/mL) with signs of hepatocellular damage, inflammation and ultimately HSC activation (increase in αSMA expression). LPS elicited an inflammatory response characterized by increased expression of cytokines. 3D-monocultures comprising only Hep displayed different responses, underlying that parenchymal and non-parenchymal cells need to be present in the system to recapitulate fibrosis. The data also suggest that pre-activated HSC may reverse to a quiescent phenotype in 3D, probably due to the more physiological conditions.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatic stellate cell; Kupffer cell; Microtissues; TGF-β1; Translational

Year:  2019        PMID: 31730938     DOI: 10.1016/j.vascn.2019.106650

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  3 in total

1.  Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.

Authors:  Xi-Xi Ni; Xiao-Yun Li; Qi Wang; Jing Hua
Journal:  J Physiol Biochem       Date:  2020-11-14       Impact factor: 4.158

2.  Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis.

Authors:  Ling Wang; Yinghao Wang; Jun Quan
Journal:  Hum Cell       Date:  2020-05-24       Impact factor: 4.174

3.  Exosomal miR-223 derived from natural killer cells inhibits hepatic stellate cell activation by suppressing autophagy.

Authors:  Ling Wang; Yinghao Wang; Jun Quan
Journal:  Mol Med       Date:  2020-09-01       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.